Prati
Conrad Russell Y. Cruz
Conrad Russell Y. Cruz
Associate Professor, Children's National Hospital
Potvrđena adresa e-pošte na childrensnational.org - Početna stranica
Naslov
Citirano
Citirano
Godina
Inducible apoptosis as a safety switch for adoptive cell therapy
A Di Stasi, SK Tey, G Dotti, Y Fujita, A Kennedy-Nasser, C Martinez, ...
New England Journal of Medicine 365 (18), 1673-1683, 2011
15732011
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013
5802013
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell …
AM Leen, A Christin, GD Myers, H Liu, CR Cruz, PJ Hanley, ...
Blood, The Journal of the American Society of Hematology 114 (19), 4283-4292, 2009
3642009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral …
PJ Hanley, CRY Cruz, B Savoldo, AM Leen, M Stanojevic, M Khalil, ...
Blood, The Journal of the American Society of Hematology 114 (9), 1958-1967, 2009
2882009
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
SH Huang, Y Ren, AS Thomas, D Chan, S Mueller, AR Ward, S Patel, ...
The Journal of clinical investigation 128 (2), 876-889, 2018
1872018
Tumor-specific T-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed Hodgkin lymphoma
CM Bollard, T Tripic, CR Cruz, G Dotti, S Gottschalk, V Torrano, ...
Journal of clinical oncology 36 (11), 1128, 2018
1602018
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
J Cano-Mejia, RA Burga, EE Sweeney, JP Fisher, CM Bollard, ...
Nanomedicine: Nanotechnology, Biology and Medicine 13 (2), 771-781, 2017
1262017
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma
U Gerdemann, U Katari, AS Christin, CR Cruz, T Tripic, A Rousseau, ...
Molecular therapy 19 (12), 2258-2268, 2011
1242011
Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes
S Naik, SK Nicholas, CA Martinez, AM Leen, PJ Hanley, SM Gottschalk, ...
Journal of Allergy and Clinical Immunology 137 (5), 1498-1505. e1, 2016
1212016
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
MD Keller, KM Harris, MA Jensen-Wachspress, VV Kankate, H Lang, ...
Blood, The Journal of the American Society of Hematology 136 (25), 2905-2917, 2020
1202020
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
ES Yvon, R Burga, A Powell, CR Cruz, R Fernandes, C Barese, T Nguyen, ...
Cytotherapy 19 (3), 408-418, 2017
1122017
CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo
PJ Hanley, JJ Melenhorst, S Nikiforow, P Scheinberg, JW Blaney, ...
Science translational medicine 7 (285), 285ra63-285ra63, 2015
1112015
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience
CR Cruz, PJ Hanley, H Liu, V Torrano, YF Lin, JA Arce, S Gottschalk, ...
Cytotherapy 12 (6), 743-749, 2010
1072010
Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4
CR Cruz, U Gerdemann, AM Leen, JA Shafer, S Ku, B Tzou, TM Horton, ...
Clinical Cancer Research 17 (22), 7058-7066, 2011
992011
The growth hormone secretagogue receptor
CRY Cruz, RG Smith
Vitamins & Hormones 77, 47-88, 2007
792007
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma
JA Shafer, CR Cruz, AM Leen, S Ku, A Lu, A Rousseau, HE Heslop, ...
Leukemia & lymphoma 51 (5), 870-880, 2010
702010
Immunotherapy of relapsed and refractory solid tumors with ex vivo expanded multi-tumor associated antigen specific cytotoxic T lymphocytes: a phase I study
AB Hont, CR Cruz, R Ulrey, B O’Brien, M Stanojevic, A Datar, S Albihani, ...
Journal of Clinical Oncology 37 (26), 2349, 2019
642019
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
PJ Hanley, DR Shaffer, CRY Cruz, S Ku, B Tzou, H Liu, ...
Cytotherapy 13 (8), 976-986, 2011
632011
Engineering the TGFβ receptor to enhance the therapeutic potential of natural killer cells as an immunotherapy for neuroblastoma
RA Burga, E Yvon, E Chorvinsky, R Fernandes, CRY Cruz, CM Bollard
Clinical Cancer Research 25 (14), 4400-4412, 2019
612019
Beyond CAR T cells: other cell-based immunotherapeutic strategies against cancer
S Patel, RA Burga, AB Powell, EA Chorvinsky, N Hoq, SE McCormack, ...
Frontiers in oncology 9, 196, 2019
572019
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20